Bolus‐Only Versus Bolus‐Plus‐Infusion Tranexamic Acid for Trauma: A Propensity Score‐Matched Study
World Journal of Surgery · 2026
DOI: 10.1002/wjs.70587 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift World Journal of Surgery, 2026. Verfasst von Soon Ki Min und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Trauma Surgery, Gachon University Gil Medical Center, Incheon, Republic of Korea. Hauptthemen laut MEDLINE: Tranexamic Acid, Wounds and Injuries, Antifibrinolytic Agents, Hemorrhage. Die Arbeit nennt 21 Literaturangaben.
Abstract (Originalsprache)
Background
The CRASH‐2 regimen for tranexamic acid (TXA) consists of a 1‐g intravenous bolus followed by a 1‐g infusion over 8 hours. The maintenance infusion may be challenging to administer during the early phase of trauma resuscitation. We compared mortality outcomes between patients receiving a 1‐g TXA bolus alone and those receiving a bolus‐plus‐infusion regimen.
Methods
We conducted a retrospective cohort study of adult trauma patients (≥ 19 years) who presented directly to the trauma bay at a regional trauma center between July 2018 and December 2023. Patients who received TXA within 3 hours of injury were included in the inter‐regimen analysis and categorized into either a 1‐g bolus‐only group or a 1‐g bolus plus 1‐g infusion group. Clinical outcomes were compared using multivariable logistic regression. To minimize selection bias and baseline imbalances, 1:1 propensity score matching was performed, followed by McNemar testing and conditional logistic regression analyses in the matched cohort.
Results
Among 5204 eligible patients, 1787 received TXA. The primary inter‐regimen cohort included 1408 patients treated within 3 hours of injury: 409 received bolus‐only TXA and 999 received bolus‐plus‐infusion TXA. Propensity score matching yielded 335 pairs. After matching, mortality did not differ significantly between the groups: in‐hospital mortality 14.0% versus 17.3% (adjusted odds ratio [aOR], 1.29; 95% confidence interval [CI], 0.84–1.97; p = 0.240), 24‐h mortality 4.5% versus 5.1% (aOR, 1.13; 95% CI, 0.57–2.27; p = 0.724), and 28‐day mortality 9.3% versus 11.9% (aOR, 1.36; 95% CI, 0.81–2.28; p = 0.243).
Conclusions
In this single‐center retrospective cohort study, a 1‐g TXA bolus alone was associated with mortality outcomes comparable to those of the conventional bolus‐plus‐infusion regimen among patients treated within 3 hours of injury. Prospective studies are warranted to validate these findings.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Trauma Surgery, Gachon University Gil Medical Center, Incheon, Republic of Korea.
- Department of Traumatology, Gachon University College of Medicine, Incheon, Republic of Korea.
ORCID-Profile: Soon Ki Min, Kang Kook Choi, Byungchul Yu, Gil Jae Lee, Min A Lee, Seunghwan Lee, Sebeom Jeon, Myungjin Jang
Zitieren
APA
Min, S. K., Choi, K. K., Yu, B., Lee, G. J., Lee, M. A., Lee, S., Jeon, S., & Jang, M. (2026). Bolus‐Only Versus Bolus‐Plus‐Infusion Tranexamic Acid for Trauma: A Propensity Score‐Matched Study. World Journal of Surgery. https://doi.org/10.1002/wjs.70587
Vancouver
Min SK, Choi KK, Yu B, Lee GJ, Lee MA, Lee S, et al. Bolus‐Only Versus Bolus‐Plus‐Infusion Tranexamic Acid for Trauma: A Propensity Score‐Matched Study. World Journal of Surgery. 2026. doi:10.1002/wjs.70587
BibTeX
@article{Min2026,
author = {Min, Soon Ki and Choi, Kang Kook and Yu, Byungchul and Lee, Gil Jae and Lee, Min A and Lee, Seunghwan and Jeon, Sebeom and Jang, Myungjin},
title = {Bolus‐Only Versus Bolus‐Plus‐Infusion Tranexamic Acid for Trauma: A Propensity Score‐Matched Study},
journal = {World Journal of Surgery},
year = {2026},
doi = {10.1002/wjs.70587}
}
EUVIMED